ALPINE IMMUNE SCIENCES, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Alpine Immune Sciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q1 2024.
  • Alpine Immune Sciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $7.32M, a 9.12% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $7.32M -$734K -9.12% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $7.51M -$709K -8.63% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 $7.7M -$684K -8.16% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $7.88M -$662K -7.75% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $8.05M -$640K -7.36% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $8.22M -$618K -6.99% Dec 31, 2022 10-K 2024-03-20
Q3 2022 $8.38M -$599K -6.67% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $8.54M -$579K -6.35% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $8.69M -$560K -6.05% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $8.84M -$564K -6% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $8.98M -$554K -5.81% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $9.12M -$556K -5.75% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $9.25M -$587K -5.97% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $9.4M -$584K -5.85% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $9.53M -$1.3M -12% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $9.67M -$1.63M -14.4% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $9.84M +$9.24M +1532% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $9.99M +$9.99M Dec 31, 2019 10-K 2021-03-18
Q3 2019 $10.8M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $11.3M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $603K Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $0 Dec 31, 2018 10-Q 2019-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.